The University of Chicago Header Logo

FH535, a ß-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.

FH535, a ß-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Oncotarget. 2016 Jul 26; 7(30):47145-47162.

View in: PubMed